LG Chem Obtains Japanese Approval for Biosimilar Autoimmune Disease Treatment
[Asia Economy Reporter Lim Chunhan] LG Chem announced on the 23rd that it has received sales approval from the Japanese Ministry of Health, Labour and Welfare for the autoimmune disease treatment Humira biosimilar (biopharmaceutical generic) 'Adalimumab BS MA' (generic name Adalimumab).
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- "He's Handsome, It's Such a Pity?"... Lawyer Responds to Bizarre 'Appearance Evaluation' of High School Girl Murder Suspect
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- "Mom, Isn't It Comfortable Living With Me?"... 'Unexpected Result' Shows Increased Drinking Out of Frustration
- "Nothing Has Changed": Union Rejects Samsung's Proposal... Further Talks Fail as Strike Proceeds
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
